Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380:1450–1462
Article
CAS
PubMed
Google Scholar
Kielar A, Fowler KJ, Lewis S et al (2018) Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY) 43:218–230
Article
Google Scholar
Tang A, Fowler KJ, Chernyak V, Chapman WC, Sirlin CB (2018) LI-RADS and transplantation for hepatocellular carcinoma. Abdom Radiol (NY) 43:193–202
Article
Google Scholar
Chernyak V, Fowler KJ, Kamaya A et al (2018) Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816–830
Article
PubMed
Google Scholar
American College of Radiology (2018) Liver Imaging Reporting and Data System version 2018 Manual. Available via: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/LI-RADS-2018-Manual-5Dec18.pdf?la=en. Accessed 11th June 2019.
Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 273:241–260
Article
PubMed
Google Scholar
Gaba RC, Lewandowski RJ, Hickey R et al (2016) Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 27:457–473
Article
PubMed
Google Scholar
Guan YS, Sun L, Zhou XP, Li X, Zheng XH (2004) Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up. World J Gastroenterol 10:3543–3548
Article
PubMed
PubMed Central
Google Scholar
Joseph FB, Baumgarten DA, Bernardino ME (1993) Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Work in progress. Radiology 186:553–556
Article
CAS
PubMed
Google Scholar
Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156
Article
CAS
PubMed
PubMed Central
Google Scholar
Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130
Article
PubMed
Google Scholar
Stauffer PR, Goldberg SN (2004) Introduction: thermal ablation therapy. Int J Hyperthermia 20:671–677
Article
CAS
PubMed
Google Scholar
Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174:323–331
Article
CAS
PubMed
Google Scholar
Thompson SM, Callstrom MR, Butters KA et al (2014) Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: in vitro and in vivo study. Lasers Surg Med 46:290–301
Article
PubMed
PubMed Central
Google Scholar
Goldberg SN, Stein MC, Gazelle GS, Sheiman RG, Kruskal JB, Clouse ME (1999) Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol 10:907–916
Article
CAS
PubMed
Google Scholar
Lin ZY, Li GL, Chen J, Chen ZW, Chen YP, Lin SZ (2016) Effect of heat sink on the recurrence of small malignant hepatic tumors after radiofrequency ablation. J Cancer Res Ther 12:C153–C158
Article
PubMed
Google Scholar
Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L (2015) Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 7:1054–1063
Article
PubMed
PubMed Central
Google Scholar
Simon CJ, Dupuy DE, Mayo-Smith WW (2005) Microwave ablation: principles and applications. Radiographics 25(Suppl 1):S69–S83
Article
PubMed
Google Scholar
Wright AS, Lee FT Jr, Mahvi DM (2003) Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 10:275–283
Article
PubMed
Google Scholar
Mulier S, Mulier P, Ni Y et al (2002) Complications of radiofrequency coagulation of liver tumours. Br J Surg 89:1206–1222
Article
CAS
PubMed
Google Scholar
Nakagomi R, Tateishi R, Shiina S et al (2014) Drastically reduced neoplastic seeding related to radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 109:774–776
Article
PubMed
Google Scholar
Rhim H (2005) Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging 30:409–418
Article
CAS
PubMed
Google Scholar
Yang B, Zan RY, Wang SY et al (2015) Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials. World J Surg Oncol 13:96
Article
PubMed
PubMed Central
Google Scholar
Brunello F, Veltri A, Carucci P et al (2008) Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43:727–735
Article
PubMed
Google Scholar
Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 127:1714–1723
Article
PubMed
Google Scholar
Lu MD, Kuang M, Liang LJ et al (2006) Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 86:801–805
PubMed
Google Scholar
Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328
Article
PubMed
PubMed Central
Google Scholar
Kutlu OC, Chan JA, Aloia TA et al (2017) Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. Cancer 123:1817–1827
Article
PubMed
Google Scholar
Xu XL, Liu XD, Liang M, Luo BM (2017) Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Radiology. https://doi.org/10.1148/radiol.2017162756:162756
European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236
Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750
Article
PubMed
Google Scholar
Vietti Violi N, Duran R, Guiu B et al (2018) Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol 3:317–325
Article
PubMed
Google Scholar
Lencioni R, de Baere T, Martin RC, Nutting CW, Narayanan G (2015) Image-guided ablation of malignant liver tumors: recommendations for clinical validation of novel thermal and non-thermal technologies - a Western perspective. Liver Cancer 4:208–214
Article
CAS
PubMed
PubMed Central
Google Scholar
Kielar A, Fowler KJ, Lewis S et al (2017) Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). https://doi.org/10.1007/s00261-017-1281-6
Article
Google Scholar
Oei T, vanSonnenberg E, Shankar S, Morrison PR, Tuncali K, Silverman SG (2005) Radiofrequency ablation of liver tumors: a new cause of benign portal venous gas. Radiology 237:709–717
Article
PubMed
Google Scholar
Kim KW, Lee JM, Choi BI (2011) Assessment of the treatment response of HCC. Abdom Imaging 36:300–314
Article
PubMed
Google Scholar
Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662
Article
CAS
PubMed
Google Scholar
Yasui D, Murata S, Ueda T et al (2018) Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study. Acta Radiol 59:266–274
Article
PubMed
Google Scholar
Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41–52
Article
PubMed
Google Scholar
Liu DM, Salem R, Bui JT et al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935
Article
PubMed
Google Scholar
Lee EW, Khan S (2017) Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma. Clin Mol Hepatol 23:265–272
Article
PubMed
PubMed Central
Google Scholar
Terzi E, Ray Kim W, Sanchez W et al (2015) Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl 21:248–257
Article
PubMed
Google Scholar
Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–442
Article
CAS
PubMed
Google Scholar
Raoul JL, Gilabert M, Piana G (2014) How to define transarterial chemoembolization failure or refractoriness: a European perspective. Liver Cancer 3:119–124
Article
PubMed
PubMed Central
Google Scholar
Brown KT, Do RK, Gonen M et al (2016) Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone. J Clin Oncol 34:2046–2053
Article
CAS
PubMed
PubMed Central
Google Scholar
Sangro B (2014) Chemoembolization and radioembolization. Best Pract Res Clin Gastroenterol 28:909–919
Article
CAS
PubMed
Google Scholar
Zivin SP, Elias Y, Ray CE Jr (2015) Tumor lysis syndrome and primary hepatic malignancy: case presentation and review of the literature. Semin Intervent Radiol 32:3–9
Article
PubMed
PubMed Central
Google Scholar
Brown DB, Geschwind JF, Soulen MC, Millward SF, Sacks D (2009) Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 20:S317–S323
Article
PubMed
Google Scholar
Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171
Article
CAS
PubMed
Google Scholar
Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335–342
Article
PubMed
Google Scholar
Facciorusso A, Mariani L, Sposito C et al (2016) Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 31:645–653
Article
CAS
PubMed
Google Scholar
Marelli L, Stigliano R, Triantos C et al (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30:6–25
Article
PubMed
Google Scholar
Kwan SW, Fidelman N, Ma E, Kerlan RK Jr, Yao FY (2012) Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl 18:727–736
Article
PubMed
PubMed Central
Google Scholar
Bisseret D, Ronot M, Abdel-Rehim M et al (2013) Intratumoral gas in hepatocellular carcinoma following transarterial chemoembolization: associated factors and clinical impact. J Vasc Interv Radiol 24:1623–1631
Article
PubMed
Google Scholar
Salem R, Mazzaferro V, Sangro B (2013) Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives. Hepatology 58:2188–2197
Article
CAS
PubMed
Google Scholar
Park MJ, Kim SY, Yoon SM et al (2014) Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography. PLoS One 9:e90327
Article
PubMed
PubMed Central
CAS
Google Scholar
Potters L, Kavanagh B, Galvin JM et al (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76:326–332
Article
PubMed
Google Scholar
Schaub SK, Hartvigson PE, Lock MI et al (2018) Stereotactic body radiation therapy for hepatocellular carcinoma: current trends and controversies. Technol Cancer Res Treat 17:1533033818790217
Article
PubMed
PubMed Central
Google Scholar
Kimura T, Takahashi S, Takahashi I et al (2015) The time course of dynamic computed tomographic appearance of radiation injury to the cirrhotic liver following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One 10:e0125231
Article
PubMed
PubMed Central
CAS
Google Scholar
Kim J, Jung Y (2017) Radiation-induced liver disease: current understanding and future perspectives. Exp Mol Med 49:e359
Article
PubMed
PubMed Central
CAS
Google Scholar
Kimura T, Takahashi S, Kenjo M et al (2013) Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: how should we evaluate treatment effects? Hepatol Res 43:717–727
Article
CAS
PubMed
Google Scholar
Lo SS, Dawson LA, Kim EY et al (2010) Stereotactic body radiation therapy for hepatocellular carcinoma. Discov Med 9:404–410
PubMed
Google Scholar
Liang SX, Zhu XD, Xu ZY et al (2006) Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65:426–434
Article
PubMed
Google Scholar
Benson R, Madan R, Kilambi R, Chander S (2016) Radiation induced liver disease: a clinical update. J Egypt Natl Canc Inst 28:7–11
Article
CAS
PubMed
Google Scholar
Hamami ME, Poeppel TD, Muller S et al (2009) SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med 50:688–692
Article
CAS
PubMed
Google Scholar
Salem R, Parikh P, Atassi B et al (2008) Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol 31:431–438
Article
PubMed
Google Scholar
Spina JC, Hume I, Pelaez A, Peralta O, Quadrelli M, Garcia Monaco R (2019) Expected and unexpected imaging findings after (90) Y transarterial radioembolization for liver tumors. Radiographics 39:578–595
Article
PubMed
Google Scholar
Hamoui N, Minocha J, Memon K et al (2013) Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres. J Vasc Interv Radiol 24:1743–1745
Article
PubMed
Google Scholar
Kim YC, Kim YH, Uhm SH et al (2010) Radiation safety issues in y-90 microsphere selective hepatic radioembolization therapy: possible radiation exposure from the patients. Nucl Med Mol Imaging 44:252–260
Article
CAS
PubMed
PubMed Central
Google Scholar
Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C (2004) Pathologic response and microdosimetry of (90) Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60:1552–1563
Article
CAS
PubMed
Google Scholar
Sangro B, Inarrairaegui M, Bilbao JI (2012) Radioembolization for hepatocellular carcinoma. J Hepatol 56:464–473
Article
PubMed
Google Scholar
Gil-Alzugaray B, Chopitea A, Inarrairaegui M et al (2013) Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology 57:1078–1087
Article
CAS
PubMed
Google Scholar
Sangro B, Gil-Alzugaray B, Rodriguez J et al (2008) Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 112:1538–1546
Article
PubMed
Google Scholar
Wahl DR, Stenmark MH, Tao Y et al (2016) Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J Clin Oncol 34:452–459
Article
CAS
PubMed
Google Scholar
Yoon SM, Lim YS, Park MJ et al (2013) Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma. PLoS One 8:e79854
Article
CAS
PubMed
PubMed Central
Google Scholar
Sapisochin G, Barry A, Doherty M et al (2017) Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma An intention-to-treat analysis. J Hepatol 67:92–99
Article
PubMed
Google Scholar
Miften M, Vinogradskiy Y, Moiseenko V et al (2018) Radiation dose-volume effects for liver SBRT. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2017.12.290
Bujold A, Massey CA, Kim JJ et al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639
Article
PubMed
Google Scholar
Salem R, Gordon AC, Mouli S et al (2016) Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 151(1155–1163):e1152
Google Scholar
Facciorusso A, Serviddio G, Muscatiello N (2016) Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: a systematic review and meta-analysis. World J Hepatol 8:770–778
Article
PubMed
PubMed Central
Google Scholar
Parikh ND, Waljee AK, Singal AG (2015) Downstaging hepatocellular carcinoma: a systematic review and pooled analysis. Liver Transpl 21:1142–1152
Article
PubMed
Google Scholar
Salem R, Gabr A, Riaz A et al (2018) Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience. Hepatology 68:1429–1440
Article
PubMed
Google Scholar
Atassi B, Bangash AK, Bahrani A et al (2008) Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics 28:81–99
Article
PubMed
Google Scholar
Cerny M, Chernyak V, Olivie D et al (2018) LI-RADS version 2018 ancillary features at MRI. Radiographics. https://doi.org/10.1148/rg.2018180052:180052
Cerny M, Bergeron C, Billiard JS et al (2018) LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features. Radiology 288:118–128
Article
PubMed
Google Scholar